{"transactions":[{"id":1006859,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T21:15:08.000Z","date":"2025-11-04","kind":"other","planned":false,"acquired":false,"shares":1600000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, Third Rock Ventures IV, L.P. (\"TRV IV \") distributed, for no consideration, 1,600,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP IV, L.P. (\"TRV GP IV \"), the general partner of TRV IV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP IV distributed, for no consideration, the Shares it received in the distribution by TRV IV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, Third Rock Ventures IV, L.P. (\"TRV IV \") distributed, for no consideration, 1,600,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP IV, L.P. (\"TRV GP IV \"), the general partner of TRV IV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP IV distributed, for no consideration, the Shares it received in the distribution by TRV IV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by TRV IV. The general partner of TRV IV is TRV GP IV. The general partner of TRV GP IV is TRV GP IV LLC. Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":4473958,"source":{"system":"sec-edgar","filing":"0001193125-25-266981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000119312525266981/ownership.xml","form_type":"4"}},{"id":1013277,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-27T20:15:03.000Z","date":"2025-10-23","kind":"sale","planned":false,"acquired":false,"shares":477401,"price":10.152,"value":4846574.952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":13386574,"source":{"system":"sec-edgar","filing":"0001193125-25-251606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525251606/ownership.xml","form_type":"4"}},{"id":1031269,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-29T20:15:05.000Z","date":"2025-09-25","kind":"sale","planned":false,"acquired":false,"shares":500000,"price":8.017,"value":4008500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.165, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or\nthe staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":13863975,"source":{"system":"sec-edgar","filing":"0001193125-25-223227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525223227/ownership.xml","form_type":"4"}},{"id":1037925,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-17T22:06:13.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":363541,"price":7.04,"value":2559328.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":14363975,"source":{"system":"sec-edgar","filing":"0001193125-25-206453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525206453/ownership.xml","form_type":"4"}},{"id":1044892,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T20:15:06.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":86459,"price":7.0395,"value":608628.1305,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":14727516,"source":{"system":"sec-edgar","filing":"0001193125-25-199177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525199177/ownership.xml","form_type":"4"}},{"id":1044891,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T20:15:06.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":642906,"price":7,"value":4500342.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":14813975,"source":{"system":"sec-edgar","filing":"0001193125-25-199177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525199177/ownership.xml","form_type":"4"}},{"id":1055817,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T20:15:09.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":302194,"price":7,"value":2115358.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":15456881,"source":{"system":"sec-edgar","filing":"0000950170-25-111457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025111457/ownership.xml","form_type":"4"}},{"id":1059319,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-21T20:15:14.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":1100000,"price":7.0116,"value":7712760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":15759075,"source":{"system":"sec-edgar","filing":"0000950170-25-110662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025110662/ownership.xml","form_type":"4"}},{"id":1285001,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-02-04T22:31:08.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":false,"shares":9166666,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Third Rock Ventures V, L.P. (\"TRV V\"). The general partner of TRV V is Third Rock Ventures GP V, L.P. (\"TRV GP V\"). The general partner of TRV GP V is TRV GP V, LLC (\"TRV GP V LLC\"). Each of TRV GP V, and TRV GP V LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":950800},"source":{"system":"sec-edgar","filing":"0000950170-25-013760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000095017025013760/ownership.xml","form_type":"4"}},{"id":1285000,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2025-02-04T22:31:08.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":false,"shares":9725709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1008786},"source":{"system":"sec-edgar","filing":"0000950170-25-013760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000095017025013760/ownership.xml","form_type":"4"}},{"id":1284999,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-02-04T22:31:08.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":false,"shares":45833334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4754002},"source":{"system":"sec-edgar","filing":"0000950170-25-013760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000095017025013760/ownership.xml","form_type":"4"}},{"id":1284998,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T22:31:08.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":true,"shares":950800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Third Rock Ventures V, L.P. (\"TRV V\"). The general partner of TRV V is Third Rock Ventures GP V, L.P. (\"TRV GP V\"). The general partner of TRV GP V is TRV GP V, LLC (\"TRV GP V LLC\"). Each of TRV GP V, and TRV GP V LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":950800,"source":{"system":"sec-edgar","filing":"0000950170-25-013760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000095017025013760/ownership.xml","form_type":"4"}},{"id":1284997,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23357,"kind":"organization","name":"Third Rock Ventures V, L.P.","position":4,"cik":"0001778071","reported_name":"Third Rock Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23358,"kind":"organization","name":"Third Rock Ventures GP V, LP","position":5,"cik":"0001977498","reported_name":"Third Rock Ventures GP V, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23359,"kind":"organization","name":"TRV GP V, LLC","position":6,"cik":"0001990717","reported_name":"TRV GP V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T22:31:08.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":true,"shares":5762788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into Common Stock on a  one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":6073958,"source":{"system":"sec-edgar","filing":"0000950170-25-013760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778071/000095017025013760/ownership.xml","form_type":"4"}},{"id":1405285,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T20:48:33.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":67400,"price":10.5305,"value":709755.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":16859075,"source":{"system":"sec-edgar","filing":"0000950170-24-107330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024107330/ownership.xml","form_type":"4"}},{"id":1411902,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-09T23:19:21.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":11.5618,"value":867135.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.54 to $11.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":16926475,"source":{"system":"sec-edgar","filing":"0000950170-24-104863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024104863/ownership.xml","form_type":"4"}},{"id":1415912,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:42:19.000Z","date":"2024-08-30","kind":"sale","planned":false,"acquired":false,"shares":175000,"price":11.5983,"value":2029702.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.52 to $11.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17001475,"source":{"system":"sec-edgar","filing":"0000950170-24-103661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024103661/ownership.xml","form_type":"4"}},{"id":1420003,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-29T20:40:22.000Z","date":"2024-08-27","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":11.5466,"value":288665.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.53 to $11.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17176475,"source":{"system":"sec-edgar","filing":"0000950170-24-101910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024101910/ownership.xml","form_type":"4"}},{"id":1427810,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T21:59:38.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":10.0928,"value":1513920.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.475, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17201475,"source":{"system":"sec-edgar","filing":"0000950170-24-099253","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024099253/ownership.xml","form_type":"4"}},{"id":1427809,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T21:59:38.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":135000,"price":9.7885,"value":1321447.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17351475,"source":{"system":"sec-edgar","filing":"0000950170-24-099253","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024099253/ownership.xml","form_type":"4"}},{"id":1444379,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T21:51:53.000Z","date":"2024-08-01","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":9.8,"value":392000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17486475,"source":{"system":"sec-edgar","filing":"0000950170-24-089474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024089474/ownership.xml","form_type":"4"}},{"id":1444378,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T21:51:53.000Z","date":"2024-07-31","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":9.9338,"value":993380.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.84 to $10.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17526475,"source":{"system":"sec-edgar","filing":"0000950170-24-089474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024089474/ownership.xml","form_type":"4"}},{"id":1444377,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T21:51:53.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":95000,"price":9.8012,"value":931114.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $9.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17626475,"source":{"system":"sec-edgar","filing":"0000950170-24-089474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024089474/ownership.xml","form_type":"4"}},{"id":1446368,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T20:15:03.000Z","date":"2024-07-26","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":9.839,"value":491950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17721475,"source":{"system":"sec-edgar","filing":"0000950170-24-087862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024087862/ownership.xml","form_type":"4"}},{"id":1448109,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T20:15:03.000Z","date":"2024-07-25","kind":"sale","planned":false,"acquired":false,"shares":100599,"price":9.8686,"value":992771.2914,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.005, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17771475,"source":{"system":"sec-edgar","filing":"0000950170-24-086894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024086894/ownership.xml","form_type":"4"}},{"id":1448108,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T20:15:03.000Z","date":"2024-07-24","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":9.8158,"value":1963160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.78 to $10.025, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":17872074,"source":{"system":"sec-edgar","filing":"0000950170-24-086894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024086894/ownership.xml","form_type":"4"}},{"id":1449414,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-24T20:15:03.000Z","date":"2024-07-23","kind":"sale","planned":false,"acquired":false,"shares":125000,"price":9.7868,"value":1223350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":18072074,"source":{"system":"sec-edgar","filing":"0000950170-24-086051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024086051/ownership.xml","form_type":"4"}},{"id":1449413,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-24T20:15:03.000Z","date":"2024-07-22","kind":"sale","planned":false,"acquired":false,"shares":262740,"price":9.7819,"value":2570096.406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":18197074,"source":{"system":"sec-edgar","filing":"0000950170-24-086051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024086051/ownership.xml","form_type":"4"}},{"id":1450522,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-22T20:15:03.000Z","date":"2024-07-18","kind":"sale","planned":false,"acquired":false,"shares":191490,"price":9.8098,"value":1878478.602,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":18459814,"source":{"system":"sec-edgar","filing":"0000950170-24-085256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024085256/ownership.xml","form_type":"4"}},{"id":1451881,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-18T20:15:03.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":550171,"price":9.7903,"value":5386339.1413,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":18651304,"source":{"system":"sec-edgar","filing":"0000950170-24-084580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024084580/ownership.xml","form_type":"4"}},{"id":1629603,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-21T22:52:28.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":162500,"price":12,"value":1950000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":19201475,"source":{"system":"sec-edgar","filing":"0000950170-24-018198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024018198/ownership.xml","form_type":"4"}},{"id":2024795,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:30:21.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":1500000,"price":0.82,"value":1230000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.801 to $0.893, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":3058204,"source":{"system":"sec-edgar","filing":"0000899243-23-004411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924323004411/doc4.xml","form_type":"4"}},{"id":2024794,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:30:21.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":2200000,"price":0.83,"value":1826000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.808 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":4558204,"source":{"system":"sec-edgar","filing":"0000899243-23-004411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924323004411/doc4.xml","form_type":"4"}},{"id":2589567,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-26T21:54:07.000Z","date":"2021-08-25","kind":"other","acquired":false,"shares":1250000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 25, 2021, Third Rock Ventures IV, L.P. (\"TRV IV\") distributed for no consideration, 1,250,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"), the general partner of TRV IV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP IV distributed, for no consideration, the Shares it received in the distribution by TRV IV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 25, 2021, Third Rock Ventures IV, L.P. (\"TRV IV\") distributed for no consideration, 1,250,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"), the general partner of TRV IV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP IV distributed, for no consideration, the Shares it received in the distribution by TRV IV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV IV. The general partner of TRV IV is TRV GP IV. The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":6758204,"source":{"system":"sec-edgar","filing":"0000899243-21-034297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321034297/doc4.xml","form_type":"4"}},{"id":2907353,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":1965294,"price":41,"value":80577054.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907352,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":4782,"price":44.73,"value":213898.86,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (11)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1965294,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907351,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":2791,"price":44,"value":122804.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1970076,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907350,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":27650,"price":42.12,"value":1164618.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1972867,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907349,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":5630,"price":41.08,"value":231280.4,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2000517,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907348,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":805050,"price":40.01,"value":32210050.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2006147,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907347,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":7412,"price":44.73,"value":331538.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7739918,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907346,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":4325,"price":44,"value":190300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7747330,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907345,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":42860,"price":42.12,"value":1805263.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7751655,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907344,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":8727,"price":41.08,"value":358505.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7794515,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907343,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":1247873,"price":40.01,"value":49927398.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7803242,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907342,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":1500000,"price":40,"value":60000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9051115,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":3079018,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":61881,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17427},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079017,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":61881,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17427},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079016,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":9920455,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2793770},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079015,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":35404286,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9970454},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079014,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":17427,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2811197,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079013,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":17427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9987881,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079012,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":2793770,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2793770,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079011,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":9970454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9970454,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3116885,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":false,"shares":15250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are directly held by Third Rock Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2132867},"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116884,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":false,"shares":39750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III  LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5559440},"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116883,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":true,"shares":2132867,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures IV, L.P. (\"TRV IV\") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are directly held by Third Rock Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2132867,"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116882,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":true,"shares":5559440,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures III, L.P. (\"TRV III\") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III  LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":5839160,"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3266901,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-02-18T22:22:11.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":49879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV IV. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":49879},"source":{"system":"sec-edgar","filing":"0000899243-20-004931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924320004931/doc4.xml","form_type":"4"}},{"id":3266900,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-02-18T22:22:11.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":342505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV IV. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":342505},"source":{"system":"sec-edgar","filing":"0000899243-20-004931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924320004931/doc4.xml","form_type":"4"}},{"id":3266899,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-18T22:22:11.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":1027516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV IV. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1027516},"source":{"system":"sec-edgar","filing":"0000899243-20-004931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924320004931/doc4.xml","form_type":"4"}},{"id":3266898,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T22:22:11.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":1419900,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures IV, L.P. (\"TRV IV\") upon conversion of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV IV. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":1419900,"source":{"system":"sec-edgar","filing":"0000899243-20-004931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924320004931/doc4.xml","form_type":"4"}},{"id":3457989,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-22T20:38:31.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":15833333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2261904},"source":{"system":"sec-edgar","filing":"0000899243-19-020029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924319020029/doc4.xml","form_type":"4"}},{"id":3457988,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T20:38:31.000Z","date":"2019-07-22","kind":"purchase","acquired":true,"shares":81250,"price":16,"value":1300000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":2343154,"source":{"system":"sec-edgar","filing":"0000899243-19-020029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924319020029/doc4.xml","form_type":"4"}},{"id":3457987,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T20:38:31.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":2261904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":2261904,"source":{"system":"sec-edgar","filing":"0000899243-19-020029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688325/000089924319020029/doc4.xml","form_type":"4"}},{"id":3882373,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-06-27T20:34:17.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":340566,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":131799},"source":{"system":"sec-edgar","filing":"0000899243-18-018339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018339/doc4.xml","form_type":"4"}},{"id":3882372,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-06-27T20:34:17.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":20102478,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7779656},"source":{"system":"sec-edgar","filing":"0000899243-18-018339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018339/doc4.xml","form_type":"4"}},{"id":3882371,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":1,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":2,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":3,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:34:17.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":7911455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares."}],"balance_after":8008204,"source":{"system":"sec-edgar","filing":"0000899243-18-018339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018339/doc4.xml","form_type":"4"}}]}